- Tytuł:
- Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph-negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.
- Autorzy:
- Źródło:
- Clinical case reports [Clin Case Rep] 2023 Dec 09; Vol. 11 (12), pp. e8289. Date of Electronic Publication: 2023 Dec 09 (Print Publication: 2023).
- Typ publikacji:
- Case Reports
Raport